|premium|

AMC stock should get short-term pop, but long term it is set to drop

  • AMC stock closes up on Thursday as markets recover from the Wednesday wipeout.
  • AMC is still way below previous spike highs, but another could be coming.
  • AMC results last week were better than expected, but debt headwinds and economic slowdown lie ahead.

AMC stock (AMC Entertainment) closed up on Thursday, and Friday could see more gains for the meme stock favorite as investors look to close out positions and end the week positively. Friday is also option expiry time, and liquidity has been terrible. Net options expiry should be on the buy-side this time, and coupled with poor liquidity should help stock markets take a leg higher. AMC should, therefore, benefit from some improved sentiment. This could continue now that we appear to be at peak fear levels after Walmart (WMT) and Target (TGT) reported this week. Retail investors have taken in some harsh lessons this year as the stock market turns south and we still feel more pain is on its way for long-term AMC holders.

Also readGameStop jumps higher as Apes celebrate Melvin Capital’s downfall

AMC Stock News: National Cinemedia stake surprises

An interesting side note being circulated by traders this morning is that AMC has taken a stake in National Cinemedia (NCMI). The latest SEC filing shows AMC now has a stake of 6.8% in the company. National CineMedia is a good fit for AMC as the company provides advertising and marketing in cinema theatres. AMC did previously hold a stake in National Cinemedia back in 2018. 

AMC Stock Forecast

We are forecasting a short-term bounce here for AMC, but unfortunately it will be long-term pain for this one. The short interest has recently spiked up a little bit. Nothing to get too excited about as the liquidity is now so much higher, so the days to cover means a short squeeze is not going to happen any time soon. A bit more risk-on sentiment would see some of those shorts likely covering and so could help short-term momentum.

AMC did not quite get to our support at $8.95 and is now back at the pivot of $13. If AMC can hold this $13 pivot, it may then set up a move to $21 if conditions stabilize and risk appetites improve slightly. AMC and many other consumer stocks have fallen sharply this year. We are currently pricing in a 50/50 chance of a recession in the US, and stocks have repriced sharply lower. This is notably the case with consumer discretionary after the Target and Walmart meltdown this week.

For now, we may have overpanicked. This is our rally thesis. More detail may bore you, but sentiment and positioning are at extremely low levels from CNN Fear and Greed, AAII and Investors Intelligence. These often lead to counter trend rallies, but are short-term in nature.

Longer term though we see the effects of inflation hitting US consumers hard, and AMC will suffer. Walmart already pointed out that consumer behavior was shifting to lower-end goods with high margin discretionary spending taking a hit. AMC sits in consumer discretionary spending. If this falls, then AMC will be in big trouble with its debt pile. It has several deferred lease payments and debt repayments due in 2023 and 2024. It will need to raise finance. It will struggle to do so in fixed income markets as its debt is trading at junk status. The 2026 bonds are yielding over 20% and trading at less than 70 cents on the dollar. That is default stuff. AMC owes $272 million in rent and has upcoming refinancing due. AMC said in its latest earnings it is burning $223 million per quarter. Its cash pile from stock sales will last about a year at that rate. Investors have already rejected more share dilution, so options will be limited. 

AMC stock chart, daily


Like this article? Help us with some feedback by answering this survey:

Premium

You have reached your limit of 3 free articles for this month.

Start your subscription and get access to all our original articles.

Subscribe to PremiumSign In

Author

Ivan Brian

Ivan Brian

FXStreet

Ivan Brian started his career with AIB Bank in corporate finance and then worked for seven years at Baxter. He started as a macro analyst before becoming Head of Research and then CFO.

More from Ivan Brian
Share:

Editor's Picks

EUR/USD tests 1.1800 barrier above 50-day EMA

EUR/USD gains ground after three days of losses, trading around 1.1790 during the Asian hours on Thursday. The 14-day Relative Strength Index momentum indicator at 47 (neutral) reflects easing momentum. The RSI below 50 keeps momentum balanced and could limit follow-through.

GBP/USD struggles near four-week low vs. USD, below 1.3500 amid BoE rate cut bets

The GBP/USD pair is seen consolidating its weekly losses registered over the past three days and oscillating in a narrow range near a four-week trough, touched during the Asians session on Thursday. Spot prices currently trade just below the 1.3500 psychological mark and seem vulnerable to slide further.

Gold consolidates below $5,000 amid geopolitical risk, hawkish FOMC Minutes

Gold extends its sideways consolidative price move through the Asian session on Thursday and remains below the $5,000 psychological mark as traders seem hesitant amid mixed cues. The US Dollar preserves its strong gains to over a one-week high in the wake of somewhat hawkish Minutes of the US Federal Reserve’s January monetary policy meeting. 

Injective token surges over 13% following the approval of the mainnet upgrade proposal

Injective price rallies over 13% on Thursday after the network confirmed the approval of its IIP-619 proposal. The green light for the mainnet upgrade has boosted traders’ sentiment, as the upgrade aims to scale Injective’s real-time Ethereum Virtual Machine architecture and enhance its capabilities to support next-generation payments. The technical outlook suggests further gains if INJ breaks above key resistance.

Mixed UK inflation data no gamechanger for the Bank of England

Food inflation plunged in January, but service sector price pressure is proving stickier. We continue to expect Bank of England rate cuts in March and June. The latest UK inflation read is a mixed bag for the Bank of England, but we doubt it drastically changes the odds of a March rate cut.

Injective token surges over 13% following the approval of the mainnet upgrade proposal

Injective price rallies over 13% on Thursday after the network confirmed the approval of its IIP-619 proposal. The green light for the mainnet upgrade has boosted traders’ sentiment, as the upgrade aims to scale Injective’s real-time Ethereum Virtual Machine architecture and enhance its capabilities to support next-generation payments.